Phase II trial of temozolomide in children with recurrent high-grade glioma

Journal of Neuro-Oncology

Volumn 77, Issue 1, 2006, Pages 89-94

  Ruggiero, A ^a   Cefalo, G ^b   Garre M L ^c   Massimino, M ^b   Colosimo, C ^d   Attinaa G ^a   Lazzareschi, I ^a   Maurizi, P ^a   Ridola, V ^a   Mazzarella, G ^a   Caldarelli, M ^a   Di Rocco, C ^a   Madon, E ^e   Abate, M E ^f   Clerico, A ^g   Sandri, A ^e   Riccardi, R ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d UNIVERSITY OF CHIETI   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Brain stem tumor; Children; High grade glioma; Temozolomide; Toxicity

Indexed keywords

CARBOPLATIN; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ETOPOSIDE; METHOTREXATE; NITROSOUREA; ONDANSETRON; TEMOZOLOMIDE; THIOTEPA; VINCRISTINE;

ADOLESCENT; ANEMIA; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW SUPPRESSION; BRAIN SURGERY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; GLIOBLASTOMA; GLIOMA; HEMATOLOGIC DISEASE; HUMAN; MALE; MULTICENTER STUDY; NAUSEA AND VOMITING; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN STUDY; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; THROMBOCYTOPENIA;

ADOLESCENT; ANTINEOPLASTIC AGENTS, ALKYLATING; BONE MARROW; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DACARBAZINE; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLIOMA; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEUTROPENIA; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 33745021711     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-005-9011-2     Document Type: Article

References (35)

1. Pizzo PA, Poplack DG: Principles and Practice of Pediatric Oncology. Williams & Wilkins, Philadelphia Lippincott, 2002, 793-798
2. Campbell JW, Pollack IF, Martinez AJ, Shultz B, High-grade astrocytomas in children: Radiologically complete resection is associated with an excellent long-term prognosis Neurosurgery 38(2): 258-264, 1996
3. Halperin EC, Multiple-fraction-per-day external beam radiotherapy for adults with supratentorial malignant gliomas J Neurooncol 14(3): 255-262, 1992
4. Packer RJ, Boyett JM, Zimmerman RA, Albright AL, Kaplan AM, Rorke LB, Selch MT, Cherlow JM, Finlay JL, Wara WM, Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Children's Cancer Group Phase I/II Trial Cancer 74(6): 1827-1834, 1994
5. Freeman CR, Krischer JP, Sanford RA, Cohen ME, Burger PC, del Carpio R, Halperin EC, Munoz L, Friedman HS, Kun LE, Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: A pediatric oncology group study Int J Radiat Oncol Biol Phys 27(2): 197-206, 1993
6. Dropcho EJ, Wisoff JH, Walker RW, Allen JC, Supratentorial malignant gliomas in childhood: A review of fifty cases Ann Neurol 22(3):355-364, 1987
7. Duffner PK, Cohen ME, Myers MH, Heise HW, Survival of children with brain tumors: SEER Program, 1973-1980 Neurology 36(5):597-601, 1986
8. Lewis J, Lucraft H, Gholkar A, UKCCSG study of accelerated radiotherapy for pediatric brain stem gliomas. United Kingdom Childhood Cancer Study Group Int J Radiat Oncol Biol Phys 38(5): 925-929, 1997
9. Gibson NW, Erickson LC, Kohn KW, DNA damage and differential cytotoxicity produced in human cells by 2-chloroethyl (methylsulfonyl)methanesulfonate (NSC 338947), a new DNA-chloroethylating agent Cancer Res 45(4): 1674-1679, 1985
10. Marzolini C, Decosterd LA, Shen F, Gander M, Leyvraz S, Bauer J, Buclin T, Biollaz J, Lejeune F: Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration. Cancer Chemother Pharmacol 42(6): 433-440, 1998. Erratum in: Cancer Chemother Pharmacol 43(5): 439-440, 1999
11. Reid JM, Stevens DC, Rubin J, Ames MM, Pharmacokinetics of 3-methyl-(triazen-1-yl)imidazole 4-carboximide following administration of temozolomide to patients with advanced cancer Clin Cancer Res 3(12 Pt 1): 2393-2398, 1997
12. O'Reilly SM, Newlands ES, Glaser MG, Brampton M, Rice-Edwards JM, Illingworth RD, Richards PG, Kennard C, Colquhoun IR, Lewis P, et al: Temozolomide: A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours. Eur J Cancer 29A(7): 940-942, 1993. Erratum in: Eur J Cancer 29A(10): 1500, 1993
13. Belanich M, Randall T, Pastor MA, Kibitel JT, Alas LG, Dolan ME, Schold SC Jr, Gander M, Lejeune FJ, Li BF, White AB, Wasserman P, Citron ML, Yarosh DB, Intracellular localization, intercellular heterogeneity of the human DNA repair protein O(6)-methylguanine-DNA methyltransferase Cancer Chemother Pharmacol 37(6): 547-555, 1996
14. Wedge SR, Porteus JK, Newlands ES, Effect of single and multiple administration of an O6-benzylguanine/temozolomide combination: An evaluation in a human melanoma xenograft model Cancer Chemother Pharmacol 40(6): 266-272, 1997
15. Friedman HS, McLendon RE, Kerby T, Dugan M, Bigner SH, Henry AJ, Ashley DM, Krischer J, Lovell S, Rasheed K, Marchev F, Seman AJ, Cokgor I, Rich J, Stewart E, Colvin OM, Provenzale JM, Bigner DD, Haglund MM, Friedman AH, Modrich PL, DNA mismatch repair and O6 alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma J Clin Oncol 16(12): 3851-3857, 1998
16. Friedman HS, Kerby T, Calvert H, Temozolomide and treatment of malignant glioma Clin Cancer Res 6(7): 2585-2597, 2000
17. Bower M, Newlands ES, Bleehen NM, Brada M, Begent RJ, Calvert H, Colquhoun I, Lewis P, Brampton MH, Multicentre CRC phase II trial of temozolomide in recurrent or progressive high grade glioma Cancer Chemother Pharmacol 40(6): 484-488, 1997
18. Newlands ES, Blackledge GR, Slack JA, Rustin GJ, Smith DB, Stuart NS, Quarterman CP, Hoffman R, Stevens MF, Brampton MH, et al, Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856) Br J Cancer 65(2): 287-291, 1992
19. Stevens MF, Hickman JA, Langdon SP, Chubb D, Vickers L, Stone R, Baig G, Goddard C, Gibson NW, Slack JA, et al, Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine Cancer Res 47(22): 5846-5852, 1987
20. Nicholson HS, Krailo M, Ames MM, Seibel NL, Reid JM, Liu-Mares W, Vezina LG, Ettinger AG, Reaman GH, Phase I study of temozolomide in children and adolescents with recurrent solid tumors: A report from the Children's Cancer Group J Clin Oncol 16(9): 3037-3043, 1998
21. Estlin EJ, Lashford L, Ablett S, Price L, Gowing R, Gholkar A, Kohler J, Lewis IJ, Morland B, Pinkerton CR, Stevens MC, Mott M, Stevens R, Newell DR, Walker D, Dicks-Mireaux C, McDowell H, Reidenberg P, Statkevich P, Marco A, Batra V, Dugan M, Pearson AD, Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group Br J Cancer 78(5): 652-661, 1998
22. Epstein F, A staging for brain stem gliomas. Cancer. 56 (S1): 1804-1806, 1985
23. Epstein F, Constantini S, Practical decisions in the treatment of pediatric brain stem tumors Pediatr Neurosurg 24(1): 24-34, 1996
24. Finlay JL, Boyett JM, Yates AJ, Wisoff JH, Milstein JM, Geyer JR, Bertolone SJ, McGuire P, Cherlow JM, Tefft M, et al, Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen Childrens Cancer Group J Clin Oncol 13(1): 112-123, 1995
25. Sposto R, Ertel IJ, Jenkin RD, Boesel CP, Venes JL, Ortega JA, Evans AE, Wara W, Hammond D, The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: Results of randomized trial A report from the Children Cancer Study Group J Neuroonco l7(2): 165-177, 1989
26. Pollack IF, Boyett JM, Finlay JL, Chemotherapy for high-grade gliomas of childhood Childs Nerv Syst 15(10): 529-544, 1999
27. Phuphanich S, Edwards MS, Levin VA, Vestnys PS, Wara WM, Davis RL, Wilson CB, Supratentorial malignant gliomas of childhood results of treatment with radiation therapy and chemotherapy J Neurosurg 60(3): 495-499, 1984
28. Walker MD, Alexander E Jr, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, Norrell HA, Owens G, Ransohoff J, Wilson CB, Gehan EA, Strike TA, Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas A cooperative clinical trial J Neurosurg 49(3): 333-343, 1978
29. Freeman CR, Perilongo G, Chemotherapy for brain stem gliomas Childs Nerv Syst 15(10): 545-553, 1999
30. Patel M, McCully C, Godwin K, Balis F, Plasma and cerebrospinal fluid pharmacokinetics of temozolomide Proc Am Soc Clin Oncol 14: 461, 1995
31. Bleehen NM, Newlands ES, Lee SM, Thatcher N, Selby P, Calvert AH, Rustin GJ, Brampton M, Stevens MF, Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma J Clin Oncol 13(4): 910-913, 1995
32. Lashford LS, Thiesse P, Jouvet A, Jaspan T, Couanet D, Griffiths PD, Doz F, Ironside J, Robson K, Hobson R, Dugan M, Pearson AD, Vassal G, Frappaz D, Temozolomide in malignant gliomas of childhood: A United Kingdom children's cancer study group and french society for pediatric oncology intergroup study J Clin Oncol 20(24): 4684-4691, 2002
33. Verschuur AC, Grill J, Lelouch-Tubiana A, Couanet D, Kalifa C, Vassal G, Temozolomide in paediatric high-grade glioma: A key for combination therapy? Br J Cancer 91: 425-429, 2004
34. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al, Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352(10): 987-996, 2005
35. Riccardi A, Mazzarella G, Cefalo G, Garrè ML, Massimino M, Barone C, Sandri A, Ridola V, Ruggiero A, Mastrangelo S, et al, Pharmacokinetics of temozolomide given three times a day in pediatric and adult patients Cancer Chemother Pharmacol 52:459-464, 2003